Vericel to Present at the 16th Annual Needham Healthcare Conference
March 28 2017 - 8:00AM
Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded
autologous cell therapies for the treatment of patients with
serious diseases and conditions, today announced that Nick
Colangelo, president and CEO, will present at the 16th Annual
Needham Healthcare Conference in New York, NY on Wednesday, April
5, 2017 at 12:10pm Eastern Time.
The presentation will be webcast live and may be
accessed from the news and events section of the Vericel website:
http://investors.vcel.com/events.cfm.
About Vericel Corporation
Vericel develops, manufactures, and markets
expanded autologous cell therapies for the treatment of patients
with serious diseases and conditions. The company markets
three cell therapy products in the United States. Vericel is
marketing MACI® (autologous cultured chondrocytes on porcine
collagen membrane), an autologous cellularized scaffold product
indicated for the repair of symptomatic, single or multiple
full-thickness cartilage defects of the knee with or without bone
involvement in adults. Carticel® (autologous cultured
chondrocytes) is an autologous chondrocyte implant for the
treatment of cartilage defects in the knee in patients who have had
an inadequate response to a prior arthroscopic or other surgical
repair procedure. Epicel® (cultured epidermal autografts) is
a permanent skin replacement for the treatment of patients with
deep dermal or full thickness burns greater than or equal to 30% of
total body surface area. Vericel is also developing
ixmyelocel-T, an autologous multicellular therapy intended to treat
advanced heart failure due to ischemic dilated cardiomyopathy
(DCM). For more information, please visit the company's
website at www.vcel.com.
Epicel®, Carticel®, and MACI® are registered
trademarks of Vericel Corporation. © 2017 Vericel Corporation. All
rights reserved.
CONTACT:
Chad Rubin
The Trout Group
crubin@troutgroup.com
(646) 378-2947
or
Lee Stern
The Trout Group
lstern@troutgroup.com
(646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Apr 2023 to Apr 2024